-+ 0.00%
-+ 0.00%
-+ 0.00%

GT Biopharma Receives FDA Clearance Of Investigational New Drug Application For GTB-5550 TriKE

Benzinga·02/03/2026 13:33:21
Listen to the news

GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026

Phase 1 protocol allows multiple solid tumor types known to express B7-H3

Unaudited proforma cash balance as of January 31, 2026 of approximately $9 million anticipated to extend cash runway through Q4 2026